Meeder Asset Management Inc. reduced its holdings in Humana Inc. (NYSE:HUM – Free Report) by 79.6% during the first quarter, Holdings Channel.com reports. The institutional investor owned 1,476 shares of the insurance provider’s stock after selling 5,762 shares during the quarter. Meeder Asset Management Inc.’s holdings in Humana were worth $256,000 at the end of the most recent quarter.
Several other hedge funds have also recently made changes to their positions in HUM. Montag A & Associates Inc. lifted its stake in Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares during the period. CoreCap Advisors LLC boosted its holdings in Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac purchased a new position in Humana during the 4th quarter valued at $27,000. Reflection Asset Management purchased a new position in Humana during the 4th quarter valued at $29,000. Finally, Global Assets Advisory LLC bought a new position in Humana in the 1st quarter worth $38,000. 92.38% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
HUM has been the topic of a number of research reports. Morgan Stanley lifted their target price on shares of Humana from $217.00 to $249.00 and gave the company an “underweight” rating in a research note on Thursday, June 4th. Needham & Company LLC started coverage on shares of Humana in a report on Wednesday, May 20th. They issued a “buy” rating for the company. William Blair assumed coverage on Humana in a research report on Wednesday, May 20th. They set an “outperform” rating on the stock. Bank of America reiterated a “neutral” rating and set a $410.00 target price on shares of Humana in a report on Monday. Finally, Raymond James Financial set a $300.00 target price on Humana in a research report on Tuesday, July 7th. Two investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating, fifteen have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $327.17.
Humana Trading Up 1.7%
NYSE:HUM opened at $404.80 on Wednesday. The firm has a market capitalization of $48.60 billion, a P/E ratio of 43.29, a PEG ratio of 2.17 and a beta of 0.71. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. Humana Inc. has a one year low of $163.11 and a one year high of $428.88. The company’s 50-day simple moving average is $358.69 and its 200 day simple moving average is $262.23.
Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. During the same quarter last year, the firm earned $11.58 earnings per share. The business’s revenue for the quarter was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, analysts forecast that Humana Inc. will post 9.46 EPS for the current fiscal year.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
See Also
- Five stocks we like better than Humana
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
